Nanosphere Announces Intent to Voluntarily Delist From NASDAQ Capital Market
June 20, 2016 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., June 20, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced that it notified the NASDAQ...
Nanosphere Announces First Quarter Results
May 16, 2016 06:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., May 16, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial results for the...
Nanosphere’s Verigene BC-GP Decreases Patient Length of Stay
March 03, 2016 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., March 03, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted molecular diagnostics, today announced publication of a study that...
Nanosphere Announces Fourth Quarter and Full Year 2015 Results, 2016 Guidance and Next Generation Verigene Progress
February 24, 2016 16:01 ET
|
Nanosphere, Inc.
Corporate Highlights and Guidance: Record fourth quarter and fiscal year revenues of $6.8 million and $21.1million, respectivelyRevenue guidance for 2016 set at $28 million to $30 millionNext...
Nanosphere to Announce Fourth Quarter Financial Results and Host Investor Call on Wednesday, February 24
February 11, 2016 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, announced today that it will...
Nanosphere Announces Record Preliminary Q4 and Full Year 2015 Results
January 06, 2016 16:01 ET
|
Nanosphere, Inc.
Preliminary Fourth Quarter Revenue of $6.8 MillionPreliminary Full Year Revenue of $21.0 Million Exceeding Guidance of $18-20 Million35 New Customer Placements For Q4 2015 NORTHBROOK, Ill., Jan. 06,...
Verigene® BC-GN Positioned to Provide Rapid Diagnosis of “Phantom Menace” Superbug
December 23, 2015 08:00 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Dec. 23, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (NASDAQ:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, confirms that the Verigene®...
Nanosphere, Inc. Announces Completion of $10 Million Registered Public Offering
December 22, 2015 16:04 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Dec. 22, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the completion...
Nanosphere, Inc. Announces $10 Million Registered Public Offering
December 17, 2015 18:32 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Dec. 17, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted and flexible molecular diagnostics, today announced the pricing of a...
Nanosphere Announces Record Q3 2015 Results
November 09, 2015 16:01 ET
|
Nanosphere, Inc.
NORTHBROOK, Ill., Nov. 9, 2015 (GLOBE NEWSWIRE) -- Nanosphere, Inc. (Nasdaq:NSPH), a company enhancing medicine through targeted molecular diagnostics, today reported financial and operating results...